Supporters

Technology and Heart Failure Therapeutics (THT) is sponsored by the Cardiovascular Research Foundation^® (CRF^®) and partially funded through educational grants from commercial supporters.  This program is made possible in part by the educational grant support of our industry colleagues who, like CRF^®, are dedicated to educating medical professionals and the public to enhance patient outcomes. CRF^® gratefully acknowledges the educational grant support from the following:

Benefactors

Vectorious Medical Technologies